Tutorials
Medpace Holdings Inc logo

Medpace Holdings Inc

$ 168.69 +3.03 (+1.83%) 10:08 PM EST
P/E:
29.29
P/B:
18.44
Market Cap:
$ 5.23B
Enterprise V:
$ 5.48B
Volume:
316.44K
Avg Vol (2M):
342.06K
Also Trade In:
Volume:
316.44K
Market Cap $:
5.23B
PE Ratio:
29.29
Avg Vol (2-Month):
342.06K
Enterprise Value $:
5.48B
PB Ratio:
18.44
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Medpace Holdings Inc
NAICS : 541714 SIC : 8731
5375 Medpace Way, Cincinnati, OH, USA, 45227
Description
Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset 0.22
Debt-to-Equity 1.36
Debt-to-EBITDA 1.5
Interest Coverage 380.73
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.58
Distress
Grey
Safe
Beneish M-Score -2.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 67.02
9-Day RSI 62.63
14-Day RSI 60.98
6-1 Month Momentum % -11.02
12-1 Month Momentum % -11.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.37
Quick Ratio 0.37
Cash Ratio 0.05
Days Sales Outstanding 44.88
Days Payable 10.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.3

Financials (Next Earnings Date:2022-10-25 Est.)

MEDP's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MEDP

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,286.273
EPS (TTM) ($) 5.76
Beta 1.33
Volatility % 42.73
14-Day RSI 60.98
14-Day ATR ($) 6.789899
20-Day SMA ($) 159.791
12-1 Month Momentum % -11.9
52-Week Range ($) 126.945 - 231
Shares Outstanding (Mil) 31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medpace Holdings Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More